For some, it is two weeks into the cycle when they might start noticing small changes, and for a majority, the primary month is when they look to see significant changes and undergo marked transformations
This pricing dynamic constrains overall market penetration and slows adoption despite the strong clinical benefits of GLP-1 therapies in weight management and glycemic control, making cost a key obstacle to broader global uptake
2022 Net Income: Gilead Sciences had a net income of $4.59 billion in 2022, a 26.23 percent decrease from $6.23 billion in 2021
Accessed 29 Oct 2025
Dentico P, Volpe A, Buongiorno R, Grattagliano I, Altomare E, Tantimonaco G, Scotto G, Sacco R, Schiraldi O